BioPartnering Conference Committees

BioNJ Members collaborate in planning multiple conference components, including company presentations, partnering meetings, plenary sessions and exhibits that convenes over 450 life sciences industry thought leaders, investors, business development professionals and academic collaborators. Various committees assist with company and investor recruitment, presentation coaching, speaker identification and program development. BioNJ’s BioPartnering Conference is designed to foster productive partnerships, provide valuable education sessions, grow the ecosystem and bolster medical innovation.

Committee Members:

Core Planning Team
J.P. Morgan – Kathleen Addison, Executive Director, Life Sciences
J.P. Morgan – Kathleen Byrne, Banking Associate
J.P. Morgan – Dana D’Amelio, Associate
J.P. Morgan – Kenneth Freelund, MBA, Executive Director
J.P. Morgan – Frank Frigo Jr., Senior Marketing Associate
J.P. Morgan – Andy Harlan, CFP, Executive Director, Banker
Johnson & Johnson Innovation – Jayen Palekar, MBA, Therapeutic Area Leader, Oncology
Johnson & Johnson Innovation – Sabina Perchik, MS, Director, Transactions – Oncology Business Development

Adiso Therapeutics – Scott Megaffin, CEO
Ashton Tweed, LTD – Jordan Warshafsky, MBA, Partner
Assetive – Alain Van Loo, Founder
Avotres Inc. – Emmie Fan, MBA, MS, Chief Business Officer
CohnReznick LLP – Ravi Raghunathan, CPA, Partner, Life Sciences Industry Leader
DLA Piper – Emilio Ragosa, JD, Partner
EisnerAmper LLP – Michael Hadjiloucas, MS, CPA, Partner-in-Charge, Corporate Tax Group
EisnerAmper LLP – John Pennett, CPA, Partner-in-Charge, National Life Sciences & Technology Group
EY – Tony Torrington, CPA, Partner
EY – Arda Ural, Ph.D., MSc, MBA, Partner, American Industry Market Leader US East HSW Market Segment Leader
EY – Joel Wagner, CPA, Partner
First Republic Bank – Nishta Rao, MBA, Managing Director, Life Science
Hart & Chin Associates, LLC – Juliet Chin-Hart, MBA, Founder & Principal
LeaderStrong – Marshall Calman, MBA, PCC, Co-Founder
LeaderStrong – Jack Levitt, MBA, EMTM, Co-Founder & Principal
Merck– Christopher Mortko, PhD, MBA, Associate Vice President, Business Development & Licensing
M.G. Miller
– Matthew G. Miller, JD, Founding Attorney
Morgan Lewis & Bockus – David C. Schwartz, JD, Partner
New Jersey Economic Development Authority – Kara Moore, Sector Lead, Life Sciences
Pharmatech Solutions
– Wayne P. Weiner, Ph.D., Principal
PricewaterhouseCoopers – Ann Mohamadi, People Partner/Managing Director, Pharmaceuticals and Life Sciences
RSM – Stephen Kemler, Director, Life Sciences Senior Analyst
RSM – Adam Marshall, Partner
RSM – Joe Wolfe, Director, Business Development
Science Branding Communications – Bernie Coccia, President & Owner
Science Branding Communications – Ed Perper, MD, CEO
Silicon Valley Bank – Anton Xavier, MSc, MBA, Director SVB Startup Banking Life Sciences
Verve Group Consulting – Larry Samilow, Co-Founder & Managing Director

BioNJ Committee Policy
Each BioNJ Committee has two Co-Committee Chairpersons, as identified and selected by BioNJ leadership and the working Committee. Each Committee Chairperson is elected for a two-year term. At BioNJ’s discretion, one Chairperson will transition off annually to allow for continuity of leadership.

Please contact Cheri Hennessy at to discuss ways to engage in bringing this Conference forward.